Paper7340985
A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry.
Hill BT and 4 others. Cancer Chemother Pharmacol, 1981. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry. Papers, record 7340985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7340985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cell Survival | Major topic |
| Neuroblastoma | Major topic |
| Animals | |
| Cells, Cultured | |
| Colony-Forming Units Assay | |
| Dose-Response Relationship, Drug | |
| Flow Cytometry | |
| Mice | |
| Neoplasms, Experimental |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 658097 | Cell cycle stage-dependent induction of G2 phase arrest by different antitumor agents. | Eur J Cancer (1965) | 1978 | https://conductscience.org/library/papers/658097 | PubMed |
| 2 | 4133816 | Cell-cycle analysis in 20 minutes. | Science | 1974 | https://conductscience.org/library/papers/4133816 | PubMed |
| 3 | 7193870 | In vitro drug assay: pharmacologic considerations. | Prog Clin Biol Res | 1980 | https://conductscience.org/library/papers/7193870 | PubMed |
| 4 | 49354 | Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. | J Cell Biol | 1975 | https://conductscience.org/library/papers/49354 | PubMed |
| 5 | 49004 | Methods and applications of flow systems for analysis and sorting of mammalian cells. | Methods Cell Biol | 1975 | https://conductscience.org/library/papers/49004 | PubMed |
| 6 | 77475 | Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. | N Engl J Med | 1978 | https://conductscience.org/library/papers/77475 | PubMed |
| 7 | 144604 | Flow microfluorometric estimation of G1 and G2 chalone inhibition of the JB-1 tumour cell cycle in vitro. | Exp Cell Res | 1977 | https://conductscience.org/library/papers/144604 | PubMed |
| 8 | 1277123 | Comparison of in vitro methods to determine drug-induced cell lethality. | Cancer Res | 1976 | https://conductscience.org/library/papers/1277123 | PubMed |
| 9 | 498131 | Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder. | Cancer Res | 1979 | https://conductscience.org/library/papers/498131 | PubMed |
| 10 | 5912615 | Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. | J Natl Cancer Inst | 1966 | https://conductscience.org/library/papers/5912615 | PubMed |
| 11 | 6943380 | Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines. | J Natl Cancer Inst | 1981 | https://conductscience.org/library/papers/6943380 | PubMed |
| 12 | 687520 | Growth of human tumour cell colonies from biopsies using two soft-agar techniques. | Br J Cancer | 1978 | https://conductscience.org/library/papers/687520 | PubMed |
| 13 | 1057547 | Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts. | J Cell Biol | 1975 | https://conductscience.org/library/papers/1057547 | PubMed |
| 14 | 6105478 | In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. | Lancet | 1980 | https://conductscience.org/library/papers/6105478 | PubMed |
| 15 | 1026329 | Age-dependent survival and cell-cycle progression of cultured cells exposed to chemotherapeutic drugs. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/1026329 | PubMed |
| 16 | 210939 | Direct cloning of human ovarian carcinoma cells in agar. | Cancer Res | 1978 | https://conductscience.org/library/papers/210939 | PubMed |
| 17 | 6987066 | Lethal and kinetic effects of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine). | Eur J Cancer (1965) | 1980 | https://conductscience.org/library/papers/6987066 | PubMed |
| 18 | 421720 | Patterns of cell survival following treatment with antitumor agents in vitro. | Eur J Cancer (1965) | 1979 | https://conductscience.org/library/papers/421720 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25929919 | Efficacy of oral Etoposide in pretreated metastatic breast cancer: a multicenter phase 2 study. | Medicine (Baltimore) | 2015 | https://conductscience.org/library/papers/25929919 | PubMed |
| 8286205 | Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8286205 | PubMed |
| 8070033 | Schedule-dependent topoisomerase II-inhibiting drugs. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8070033 | PubMed |
| 8070031 | Etoposide dosage and pharmacodynamics. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8070031 | PubMed |
| 7647335 | Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer. | Breast Cancer Res Treat | 1995 | https://conductscience.org/library/papers/7647335 | PubMed |
| 7497587 | Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7497587 | PubMed |
| 6861265 | Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6861265 | PubMed |
| 6540761 | Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro. | Invest New Drugs | 1984 | https://conductscience.org/library/papers/6540761 | PubMed |
| 6488441 | Pharmacokinetic study of VM26 given as a prolonged IV infusion to ovarian cancer patients. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6488441 | PubMed |
| 6371370 | Predictive tests in cancer chemotherapy. A reappraisal. | Klin Wochenschr | 1984 | https://conductscience.org/library/papers/6371370 | PubMed |
| 4039488 | Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line. | Urol Res | 1985 | https://conductscience.org/library/papers/4039488 | PubMed |
| 3815726 | Effects of N-trifluoroacetyladriamycin-14-valerate (AD-32) on human bladder tumor cell lines. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3815726 | PubMed |
| 3624301 | Kinetic and survival response of the M14 cell line to lonidamine associated with adriamycin or hyperthermia. | J Cancer Res Clin Oncol | 1987 | https://conductscience.org/library/papers/3624301 | PubMed |
| 3297462 | The clinical pharmacology of etoposide and teniposide. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3297462 | PubMed |
| 2824081 | Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/2824081 | PubMed |
| 2720889 | Initial and early effects of adriamycin in murine sarcoma 180 cannot be restored in a resistant subline by increasing the uptake and external concentration of the drug. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2720889 | PubMed |
| 2452031 | Degradation of melphalan in vitro: rationale for the use of continuous exposure in chemosensitivity assays. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/2452031 | PubMed |
| 1643692 | Do anticancer agents reach the tumor target in the human brain? | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1643692 | PubMed |
| 1600600 | Toxicity and metabolism of 3'-deoxyadenosine N1-oxide in mice and Ehrlich ascites tumor cells. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1600600 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7340985
GET https://conductscience.org/api/papers/v1/7340985/authors